Wuhan Landing Intelligence Medical Co., Ltd.
About Us

About Us

Company Profile

Landing Med aims to make early cancer detection technologies accessible to all. We provide affordable AI cytology and digital pathology scanner options as well as services for pathologists, cytologists and governments. By integrating automation, digital, AI, and cloud computing technologies into Pap smear testing, our lab successfully screened 1 million cervical cytology cases in 50 days.

Client Testimonials

Dr. Jing Ma
Dr. Jing Ma
Professor of Public Health at Tsinghua University

Landing Med’s revolutionary end-to-end AI-powered cervical cancer screening model gives China hope to achieve the 2030 WHO cervical cancer elimination strategy. Countries with high demand for screening but limited cytopathology resources, such as low and middle-income countries, can consider AI-assisted solutions like Landing Med’s.”


Dr. Gang Zhou
Dr. Gang Zhou
Doctor at Wuhan University School of Stomatology

“Landing Med’s DNA ploidy technology for oral cancer primary diagnosis is well proven and effective.”


Dr. Yongrong Mao
Dr. Yongrong Mao
Former President of Hubei Province Cytopathology Association

“Landing Med is China’s benchmark for population-based cervical cancer screening.”


Dr. Talat Zehra
Dr. Talat Zehra
Histopathologist at Jinnah Sindh Medical University Karachi

"Landing Med's compact LD Patho 320A digital slide scanners and high-throughput Cyto 2200 cytology slide scanner series provide an efficient solution for pathology researchers."

Dr. Jing Ma
Dr. Jing Ma
Professor of Public Health at Tsinghua University

Landing Med’s revolutionary end-to-end AI-powered cervical cancer screening model gives China hope to achieve the 2030 WHO cervical cancer elimination strategy. Countries with high demand for screening but limited cytopathology resources, such as low and middle-income countries, can consider AI-assisted solutions like Landing Med’s.”


Dr. Gang Zhou
Dr. Gang Zhou
Doctor at Wuhan University School of Stomatology

“Landing Med’s DNA ploidy technology for oral cancer primary diagnosis is well proven and effective.”


Dr. Yongrong Mao
Dr. Yongrong Mao
Former President of Hubei Province Cytopathology Association

“Landing Med is China’s benchmark for population-based cervical cancer screening.”


Dr. Talat Zehra
Dr. Talat Zehra
Histopathologist at Jinnah Sindh Medical University Karachi

"Landing Med's compact LD Patho 320A digital slide scanners and high-throughput Cyto 2200 cytology slide scanner series provide an efficient solution for pathology researchers."